| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Douglas Richard is a Director at MAXCYTE, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 12 buys and 0 sells.
Estimated insider holdings value: $966K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | MXCT Maxcyte, Inc. | - | Buy | 80,000 | $1.39 | $111,040.00 | +53.1% | +12.3% | - | |
| Mar 29, 2023 | MXCT Maxcyte, Inc. | Director | Buy | 80,000 | $4.32 | $345,480.00 | +400.0% | +0.5% | -5.0% | |
| Nov 22, 2021 | MXCT Maxcyte, Inc. | Director | Buy | 20,000 | $11.12 | $222,400.00 | New | -41.4% | -42.4% | |
| Mar 16, 2020 | ALDX Aldeyra Therapeutics, Inc. | Director | Buy | 40,000 | $2.75 | $110,000.00 | +47.1% | - | - | |
| Sep 13, 2019 | ALDX Aldeyra Therapeutics, Inc. | Director | Buy | 5,000 | $6.00 | $30,000.00 | +6.3% | - | - | |
| Sep 12, 2019 | ALDX Aldeyra Therapeutics, Inc. | Director | Buy | 20,000 | $5.89 | $117,805.00 | +15.4% | - | - | |
| Sep 10, 2019 | ALDX Aldeyra Therapeutics, Inc. | Director | Buy | 20,000 | $5.00 | $99,963.00 | +22.2% | - | - | |
| May 11, 2017 | NVAX Novavax Inc | Director | Buy | 200,000 | $0.93 | $185,780.00 | +57.1% | - | - | |
| Feb 17, 2017 | ALDX Aldeyra Therapeutics, Inc. | Director | Buy | 40,000 | $4.50 | $180,000.00 | New | - | - | |
| Sep 21, 2016 | NVAX Novavax Inc | Director | Buy | 100,000 | $1.72 | $172,010.00 | +40.0% | - | - |